Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2025 Earnings Call Transcript May 1, 2025
Madrigal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-3.32, expectations were $-3.62.
Operator: Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals’ First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. As a reminder, today’s...
